首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury.
【24h】

Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury.

机译:经典补体途径的阻断抑制了内皮粘附分子的表达,并使缺血性心肌免受再灌注损伤。

获取原文
获取原文并翻译 | 示例
           

摘要

Myocardial injury after ischemia (I) and reperfusion (R) is related to leukocyte activation with subsequent release of cytokines and oxygen-derived free radicals as well as complement activation. In our study, the cardioprotective effects of exogenous C1 esterase inhibitor (C1 INH) were examined in a rat model of myocardial I + R (i.e., 20 min + 24 hr or 48 hr). The C1 INH (10, 50 and 100 U/kg) administered 2 min before reperfusion significantly attenuated myocardial injury after 24 hr of R compared to vehicle treated rats (P < .001). Further, cardiac myeloperoxidase activity (i.e., a marker of PMN [polymorphonuclear leukocyte] accumulation) in the ischemic area was significantly reduced after C1 INH treatment compared to vehicle treated animals (0.81 +/- 0.1, 0.34 +/- 0.13, 0.13 +/- 0.1 vs. 1.44 +/- 0.3 U/100 mg tissue, P < .001). In addition, C1 INH (100 U/kg) significantly attenuated myocardial injury and neutrophil infiltration even after 48 hr of reperfusion compared to vehicle treatment. Immunohistochemical analysis of ischemic-reperfused myocardial tissue demonstrated activation of classical complement pathway by deposition of C1q on cardiac myocytes and cardiac vessels. In addition, expression of the endothelial adhesion molecules P-selectin and intercellular adhesion molecule 1 (ICAM-1) was observed after reperfusion of the ischemic myocardium. In this regard, C1 INH administration abolished expression of P-selectin and ICAM-1 on the cardiac vasculature after myocardial ischemia and reperfusion. Blocking the classical complement pathway by exogenous C1 INH appears to be an effective means to preserve ischemic myocardium from injury after 24 and 48 hr of reperfusion. The mechanisms of this cardioprotective effect appears to be due to blocking of complement activation and reduced endothelial adhesion molecule expression with subsequent reduced PMN-endothelium interaction, resulting in diminished cardiac necrosis.
机译:缺血(I)和再灌注(R)后的心肌损伤与白细胞激活有关,随后释放细胞因子和氧衍生的自由基以及补体激活。在我们的研究中,在心肌I + R大鼠模型(即20分钟+ 24小时或48小时)中检查了外源C1酯酶抑制剂(C1 INH)的心脏保护作用。与赋形剂处理的大鼠相比,在再灌注前2分钟施用C1 INH(10、50和100 U / kg)可显着减轻R后24小时的心肌损伤(P <.001)。此外,与媒介物处理的动物相比,C1 INH治疗后缺血区域的心肌髓过氧化物酶活性(即PMN [多形核白细胞]积累的标志物)显着降低(0.81 +/- 0.1、0.34 +/- 0.13、0.13 + / -0.1 vs. 1.44 +/- 0.3 U / 100 mg组织,P <.001)。此外,与媒介物治疗相比,即使再灌注48小时后,C1 INH(100 U / kg)仍显着减轻了心肌损伤和中性粒细胞浸润。缺血再灌注心肌组织的免疫组织化学分析表明经典补体途径是通过C1q在心肌细胞和血管上的沉积而激活的。另外,在缺血心肌再灌注后观察到内皮粘附分子P-选择蛋白和细胞间粘附分子1(ICAM-1)的表达。在这方面,在心肌缺血和再灌注后,C1 INH给药取消了P-选择蛋白和ICAM-1在心脏血管上的表达。通过外源性C1 INH阻断经典补体途径似乎是使缺血性心肌免受再灌注24和48小时后损伤的有效手段。这种心脏保护作用的机制似乎是由于补体激活的阻断和内皮粘附分子表达的降低以及随后PMN-内皮相互作用的降低,从而导致了心脏坏死的减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号